mRNA-1273 Archives

What’s In That Hand Sanitiser?

4 April 2022

Learn From Parabens. Over recent years, there has been much greater awareness of the use of parabens in cosmetics and toiletries. Many products have become ‘parabens-free’ as increased research has shown the effects of parabens 𝘪𝘯 𝘷𝘪𝘷𝘰. As xenoestrogen, parabens molecularly mimic naturally-occurring estrogen. They function as selective estrogen receptor modulators, becoming synthetic ligands that […]

Nitric Oxide’s Role In Anti-Adhesion And Anti-Coagulation.

13 December 2021

Background. SARS-CoV-2’s Achilles’ heel has always been vitamin D in general and nitric oxide in particular. We first explained the relevance of vitamin D in July 2020, identifying the correlation between vitamin D deficiency and COVID-19 mortality rates and the key role of exposure to photosynthesis of vitamin D from exposure to UVB that occurs […]

How Low Is The SARS-CoV-2 Mortality Rate?

13 September 2021

We All Grew Up With Coronaviruses, As Did All Our Ancestors. To understand the relevance of mortality rate, you have to appreciate that coronaviruses first became pathogenic to humans in the range 12,000 – 10,000 years ago, as a consequence of the first interaction between humans and livestock that occurred in the early Holocene. Mankind […]

Antiphospholipid Antibodies And COVID-19 Vaccines.

25 August 2021

Background. As early as October 2020 – over ten months ago – we explained why a vaccine was not needed and would not be effective. That’s a vaccine using its correct medical definition, i.e. a prophylactic treatment providing long-term or lifetime protection. All of the four main treatment candidates being injected – Vaxzevria; BNT126b2; mRNA-1273 […]

Why Is Nitric Oxide’s Key Role Ignored?

28 July 2021

Role In The Innate Immune Response. It is a year since we first identified the significance of vitamin D in respect of SARS-CoV-2. Through the vitamin D pathways it can both prevent viral infection and attenuate disease progression and severity. Yet the role of vitamin D-modulated nitric oxide remains largely ignored and dismissed by the NHS as […]

Why Delta / B1.617.2 Is NOT A Problem.

6 July 2021

Just What Is Different About Delta? B1.617.2/Delta is apparently still spreading. This is unsurprising given that it has been occurring globally for over eight months. At least the WHO has finally applied a nomenclature to the main SARS-CoV-2 variants, adding to the existing PANGO and Nextstrain designations. This validates something we first highlighted four months […]

SARS-COV-2’s Defences Against Detection.

18 May 2021

What Variants Want. Considerable coverage is being given to variant B1.617. This is the ‘Indian’ variant if you use the incorrect basis of giving single country, geographical names to variants that appear globally across multiple variants and are not new, having been in existence for months and in some cases, over a year. As part […]

Questions For Those Offering You A ‘Vaccine’.

4 May 2021

Beware ‘Excited’ Non-Healthcare Workers. As another cohort is now to be offered the antivirals (they are not vaccines), it is apposite to set out some questions to ask those who are falling over themselves to vaccinate you. There is an irony in the fact that reception staff at GPs’ surgeries who are usually obdurate and […]

Is Ivermectin Another ‘Wonderdrug’?

21 April 2021

Is This Remdesivirmania Redux? Ivermectin is the subject of increasing coverage and concomitant hysteria around it being another ‘wonderdrug’ for the treatment of SARS-CoV-2. It has been touted as a potential treatment since the days of remdesivir, chloroquine, hydroxychloroquine and lopinavir. We picked apart remdesivir in October 2020, days after it was approved by the […]

These ‘Vaccines’ Become More Dangerous By The Day.

15 April 2021

Treatments Targeting The S Protein Were Already Ineffective. We have been vehement critics of the miracle ‘wonderdrug’ antivirals (they are not vaccines) rushed onto the market in recent months. In October 2020, we first set out the difference between vaccines and antivirals and highlighted the risks in RNA/mRNA vaccine candidates: these fall into the category […]